Chemed Co. (NYSE:CHE – Get Free Report) CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Chemed Price Performance
Shares of Chemed stock opened at $595.86 on Friday. The stock has a market cap of $8.72 billion, a P/E ratio of 30.11, a P/E/G ratio of 2.15 and a beta of 0.43. The stock’s 50 day simple moving average is $552.41 and its 200-day simple moving average is $563.97. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62.
Chemed Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend is Monday, February 24th. Chemed’s payout ratio is presently 10.05%.
Analysts Set New Price Targets
Institutional Trading of Chemed
Institutional investors have recently made changes to their positions in the company. Cim LLC raised its position in Chemed by 2.2% in the fourth quarter. Cim LLC now owns 2,008 shares of the company’s stock valued at $1,064,000 after purchasing an additional 44 shares during the period. Jefferies Financial Group Inc. raised its position in Chemed by 335.0% in the fourth quarter. Jefferies Financial Group Inc. now owns 1,453 shares of the company’s stock valued at $770,000 after purchasing an additional 1,119 shares during the period. United Advisor Group LLC raised its position in Chemed by 25.1% in the fourth quarter. United Advisor Group LLC now owns 807 shares of the company’s stock valued at $428,000 after purchasing an additional 162 shares during the period. Ascent Group LLC purchased a new stake in Chemed in the fourth quarter valued at approximately $258,000. Finally, Parr Mcknight Wealth Management Group LLC purchased a new stake in Chemed in the fourth quarter valued at approximately $917,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading
- Five stocks we like better than Chemed
- Why Invest in 5G? How to Invest in 5G Stocks
- MarketBeat Week in Review – 03/03 – 03/07
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Steady ETFs for Cautious Investors Facing Market Turbulence
- High Flyers: 3 Natural Gas Stocks for March 2022
- Is Myers Industries Poised for a Breakout?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.